JP2015512936A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512936A5
JP2015512936A5 JP2015505730A JP2015505730A JP2015512936A5 JP 2015512936 A5 JP2015512936 A5 JP 2015512936A5 JP 2015505730 A JP2015505730 A JP 2015505730A JP 2015505730 A JP2015505730 A JP 2015505730A JP 2015512936 A5 JP2015512936 A5 JP 2015512936A5
Authority
JP
Japan
Prior art keywords
fucosyl
sialyl lactose
prebiotic composition
oligosaccharide
sialyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015505730A
Other languages
English (en)
Other versions
JP2015512936A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/030764 external-priority patent/WO2013154725A1/en
Publication of JP2015512936A publication Critical patent/JP2015512936A/ja
Publication of JP2015512936A5 publication Critical patent/JP2015512936A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. シアリルラクトースおよびフコシルオリゴ糖から実質的になるプレバイオティクス組成物であって、前記シアリルラクトースが、３’−シアリルラクトース（３’−ＳＬ）、６’−シアリルラクトース（６’−ＳＬ）、またはこれらの混合物であり、ならびに前記フコシルオリゴ糖が、α１，２−フコシル、α１，３−フコシル、および／またはα１，４−フコシル残基を含む、プレバイオティクス組成物。
JP2015505730A 2012-04-13 2013-03-13 プレバイオティクス組成物およびその使用方法 Pending JP2015512936A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261623868P 2012-04-13 2012-04-13
US61/623,868 2012-04-13
PCT/US2013/030764 WO2013154725A1 (en) 2012-04-13 2013-03-13 Prebiotic compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2015512936A JP2015512936A (ja) 2015-04-30
JP2015512936A5 true JP2015512936A5 (ja) 2016-05-12

Family

ID=49328018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015505730A Pending JP2015512936A (ja) 2012-04-13 2013-03-13 プレバイオティクス組成物およびその使用方法

Country Status (6)

Country Link
US (1) US20150265661A1 (ja)
EP (1) EP2836218A4 (ja)
JP (1) JP2015512936A (ja)
CN (1) CN104507483A (ja)
MX (1) MX2014012362A (ja)
WO (1) WO2013154725A1 (ja)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2767043C (en) 2009-07-06 2020-07-14 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2014036182A2 (en) 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP2885977A1 (en) * 2013-12-19 2015-06-24 Agriculture and Food Development Authority (TEAGASC) An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
EP3209673B2 (en) 2014-10-24 2023-07-26 Glycom A/S Mixtures of human milk oligosaccharides
ES2856053T3 (es) * 2014-10-29 2021-09-27 Glycom As Composición sintética y procedimiento para promover la cicatrización de la mucosa
WO2016066175A1 (en) * 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
KR102511878B1 (ko) 2014-10-30 2023-03-20 캘리포니아 인스티튜트 오브 테크놀로지 신경발달 장애에서의 행동을 개선하기 위한 박테리아를 포함하는 조성물 및 방법
CN107106616A (zh) 2014-10-30 2017-08-29 加利福尼亚技术学院 包括改善神经发育障碍行为的细菌的组合物和方法
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
CN107106584A (zh) 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
AU2018205072B2 (en) * 2014-12-23 2020-05-21 Cj Bioscience, Inc. Immune modulation
SI3065748T1 (en) * 2014-12-23 2018-05-31 4D Pharma Research Limited Severe bacteroid tethethioomycron and its use in reducing inflammation
ME03077B (me) 2014-12-23 2019-01-20 4D Pharma Res Ltd Pirinski polipepтid i imunska modulacija
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
MA51639A (fr) 2015-06-15 2020-04-15 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3206700B1 (en) 2015-06-15 2019-06-05 4D Pharma Research Limited Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180267A1 (es) 2015-06-15 2018-02-06 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
EP3368046B1 (en) * 2015-10-28 2022-07-27 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
WO2017071716A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
EP3377071B1 (en) * 2015-11-17 2024-01-10 Glycom A/S Human milk oligosaccharides for treating antibiotic associated complications
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
LT3209310T (lt) 2015-11-20 2018-04-25 4D Pharma Research Limited Kompozicijos, apimančios bakterinius kamienus
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017103850A1 (en) 2015-12-15 2017-06-22 Glycom A/S Mixture of hmos
NZ745678A (en) 2016-03-04 2019-03-29 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
WO2017160711A1 (en) * 2016-03-14 2017-09-21 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
DK3452050T3 (da) * 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea
EP3458073B1 (en) 2016-05-19 2023-10-25 Glycom A/S Use of human milk oligosaccharides for treating migraine in patients with inflammatory bowel syndrome
SG11201811227QA (en) 2016-07-01 2019-01-30 Evolve Biosystems Inc Method for facilitating maturation of the mammalian immune system
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
MX2019000881A (es) 2016-07-28 2019-07-01 Fonterra Cooperative Group Ltd Producto lacteo y proceso.
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
EP3554518A4 (en) 2016-12-15 2020-07-29 The Board of Trustees of the Leland Stanford Junior University COMPOSITIONS AND METHODS FOR MODULATING THE GROWTH OF A GENETICALLY MODIFIED INTESTINAL BACTERIAL CELL
WO2018155995A1 (ko) * 2017-02-27 2018-08-30 한국생명공학연구원 시아릴락토오스를 유효성분으로 포함하는 항균용 조성물
CN110730665A (zh) * 2017-04-07 2020-01-24 儿童医院医疗中心 用2’-岩藻糖基乳糖化合物治疗炎症性肠病
JP2020520911A (ja) 2017-05-22 2020-07-16 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
PL3804737T3 (pl) 2017-06-14 2022-09-12 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
TW201919670A (zh) 2017-06-14 2019-06-01 英商4D製藥研究有限公司 包含細菌品系之組成物
MX2020004133A (es) * 2017-10-04 2020-08-13 Univ California Oligosacaridos inmunomoduladores.
BR112020010843A2 (pt) * 2017-11-30 2020-11-10 Glycom A/S oligossacarídeos do leite humano e composições sintéticas desses para modulação da microbiota
WO2019123316A1 (en) * 2017-12-22 2019-06-27 Glycom A/S Composition comprising hmos for preventing or reducing nociception
AU2019232004A1 (en) * 2018-03-08 2020-10-01 Plexus Worldwide Llc Compositions and methods for skin renewal
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
US20220022515A1 (en) 2019-02-25 2022-01-27 Nutribam Bv Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
CN110257299B (zh) * 2019-07-11 2022-06-10 锦州医科大学 一种阴沟肠杆菌在促进反刍动物生长的应用
CN112869168B (zh) * 2019-11-29 2023-06-06 内蒙古伊利实业集团股份有限公司 可提高胃肠道免疫能力的益生菌益生元组合物及其应用
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
CN111363671B (zh) * 2020-02-26 2023-07-21 天津医科大学 一种肠道厌氧微生物培养瓶及其制备方法
WO2021197492A1 (zh) * 2020-04-03 2021-10-07 内蒙古伊利实业集团股份有限公司 可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN112841543A (zh) * 2021-01-28 2021-05-28 重庆周师兄餐饮文化有限公司 一种麻辣脆的加工方法
CN112890200B (zh) * 2021-03-08 2021-11-12 合生元（广州）健康产品有限公司 用于促进低体重婴幼儿生长追赶的一种营养组合物
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN117615661A (zh) * 2021-07-09 2024-02-27 雀巢产品有限公司 长双歧杆菌过渡型微生物的用途
CN113796545B (zh) * 2021-09-13 2022-09-13 合生元（广州）健康产品有限公司 调节肠道免疫功能的母乳低聚糖组合物及其应用
KR102411242B1 (ko) * 2021-10-18 2022-06-22 큐티스바이오 주식회사 클렙시엘라 아에로제네스의 피부 상태 개선 용도
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US20060127546A1 (en) * 2004-08-27 2006-06-15 Purac Biochem B.V. Use of glycine and/or glycine derivatives as antibacterial agent against gram negative bacterial pathogens in foods and/or drinks
CA2767043C (en) * 2009-07-06 2020-07-14 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
CN106072654A (zh) * 2010-04-27 2016-11-09 N·V·努特里奇亚 6’‑唾液酸化乳糖在婴儿和幼儿营养物中的用途
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
MY197622A (en) * 2010-12-31 2023-06-28 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
PL2672844T3 (pl) * 2011-02-10 2015-04-30 Nestec Sa Modulowanie rozwoju bifidobakterii z użyciem kombinacji oligosacharydów występujących w ludzkim mleku

Similar Documents

Publication Publication Date Title
JP2015512936A5 (ja)
CN302072736S (zh) 水龙头（hda1715l）
CN302064961S (zh) 水龙头（hda1815l）
CN302061246S (zh) 门夹（2745）
CN302533123S (zh) 全封闭冰箱门锁（二）
CN302494800S (zh) 拉手（6）
CN302494801S (zh) 拉手（7）
CN302443791S (zh) 柜子（高柜）
CN302357283S (zh) 炕几（816266）
CN302357289S (zh) 炕几（816095）
CN302570606S (zh) 洋间扇（s35115r、s35116rt）
CN302487805S (zh) 拉手（5）
CN302134782S (zh) 水龙头（面盆-0007）
CN302155521S (zh) 水龙头（面盆-0006）
CN302533124S (zh) 全封闭冰箱门锁（一）
CN302533098S (zh) 拉手（1）
CN302527101S (zh) 冰箱（175）
CN302527074S (zh) 冰箱（122）
CN302527089S (zh) 冰箱（157）
CN302527063S (zh) 冰箱（156）
CN302527064S (zh) 冰箱（171）
CN302527065S (zh) 冰箱（112）
CN302527066S (zh) 冰箱（170）
CN302527073S (zh) 冰箱（123）
CN302527059S (zh) 冰箱（168）